United Therapeutics Stock Forecast - Rate Of Daily Change
| UTHR Stock | USD 367.36 3.03 0.83% |
United Stock Forecast is based on your current time horizon. Although United Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of United Therapeutics' systematic risk associated with finding meaningful patterns of United Therapeutics fundamentals over time.
United |
| Previous Rate Of Daily Change | Rate Of Daily Change | Trend |
| 1.01 | 1.01 |
| Check United Therapeutics Volatility | Backtest United Therapeutics | Information Ratio |
United Therapeutics Trading Date Momentum
| On November 21 2024 United Therapeutics was traded for 367.36 at the closing time. The top price for the day was 370.34 and the lowest listed price was 361.58 . The trading volume for the day was 202 K. The trading history from November 21, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 0.04% . |
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
| Compare United Therapeutics to competition |
Other Forecasting Options for United Therapeutics
For every potential investor in United, whether a beginner or expert, United Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. United Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in United. Basic forecasting techniques help filter out the noise by identifying United Therapeutics' price trends.United Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with United Therapeutics stock to make a market-neutral strategy. Peer analysis of United Therapeutics could also be used in its relative valuation, which is a method of valuing United Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
United Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of United Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of United Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
United Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how United Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading United Therapeutics shares will generate the highest return on investment. By undertsting and applying United Therapeutics stock market strength indicators, traders can identify United Therapeutics entry and exit signals to maximize returns.
United Therapeutics Risk Indicators
The analysis of United Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in United Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting united stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.21 | |||
| Semi Deviation | 1.89 | |||
| Standard Deviation | 1.71 | |||
| Variance | 2.94 | |||
| Downside Variance | 4.08 | |||
| Semi Variance | 3.57 | |||
| Expected Short fall | (1.14) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with United Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if United Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with United Stock
Moving against United Stock
| 0.74 | PALI | Palisade Bio | PairCorr |
| 0.66 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.64 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.59 | INZY | Inozyme Pharma | PairCorr |
| 0.54 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
The ability to find closely correlated positions to United Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace United Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back United Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling United Therapeutics to buy it.
The correlation of United Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as United Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if United Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for United Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for United Stock Analysis
When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.